PULM
PULM
NASDAQ · Pharmaceuticals

Pulmatrix Inc

$1.40
-0.04 (-2.78%)
As of Sep 21, 5:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +224.3% upside
Low Target $3.16
Average Target $4.54
High Target $6.69
Current Price $1.40
Current
$1.40
Target
$4.54
$3.16 $4.54 avg $6.69
Scenario Analysis
Bear Case
$3.16
125.7%
Low target
Base Case
$4.54
+224.3%
Avg target
Bull Case
$6.69
+377.9%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$5.50
-74.5% from high
52-Week Low
$1.16
+20.7% from low
Target vs 52W High
$4.54
-17.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%